A comparative study of modified kligmans regimen with a combination of 4-n-butylresorcinol, α- arbutin and licorice extract in the treatment of melasma

 

D Sreeja^1*, V Haritha², M Madhavi Latha³

 

¹Postgraduate, ²Assistant Professor, ³Professor, Department Of DVL, Santhiram Medical College and General Hospital, NH-40, Nandyal, Andhra Pradesh, INDIA.

 

 REFERENCES

1. Niti khunger , shikha bansal , rajat kandhari – disorders of hyper pigmentation, 4^th edition IADVL Text book of dermatology, page no – 1351 – 1352
2. Nanja van Geel and Reinhart Speeckaert , Department of Dermatology, Ghent University Hospital, Ghent, Belgium , Acquired Pigmentary Disorders, Rooks Text book of dermatology, volume - 3 ; page no 88.10 – 88.12.
3. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 2006;55:1048–65.
4. Picardo M, Carrera M. New and experimental treatments of cloasma and other hypermelanoses. Dermatol Clin 2007;25:353–62.
5. Topical treatment of melasma,Debabrata Bandyopadhyay, IJDVL , India Year : 2009 , Volume : 54 , Issue : 4 , Page : 303-309.
6. Comparative efficacy of Kligman's regimen over other topical therapies in treatment of Melasma , Department of DVL, Suma Patil, S.K. Patil - M.R. Medical College, Gulbarga.
7. L. Kolbe et al; 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation; JEADV 2013, 27 (Suppl.1), 19–23.
8. NT Madan Mohan, adarsh gowda, ashok Kumar Jaiswal, BC sharath Kumar, P shilpashree,Bilugumba Gangaboraiah; Assessment of efficacy, safety, and tolerability of 4-n-butylresorcinol 0.3% cream: an Indian multicentric study on melasma; Clinical, Cosmetic and Investigational Dermatology 2016:9 21–27.
9. Saman Ahmad Nasrollahi , Maede Sabet Nematzadeh; Evaluation of the safety and efficacy of a triple combination cream (hydroquinone, tretinoin, and fluocinolone) for treatment of melasma in Middle Eastern skin; Clinical, Cosmetic and Investigational Dermatology 2019:12 437–444.
10. Rashmi Sarkar, Shikha Chugh, Vijay K Garg; Newer and upcoming therapies for melasma;IJDVL, 2012 ; Volume : 78, Issue : 4; Page : 417-428.
11. Sun Young Huh, M.D.,Jung-Won Shin, M.D.The Efficacy and Safety of 4-n-butylresorcinol for the Treatment of Melasma: A Randomized Controlled Split-face Trial; Ann Dermatol. 2010 Feb; 22(1): 21–25.
12. Grimes P et al, Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis. 2006;77(3):177–184.
13. Arellano I, Cestari T, Ocampo-Candiani J, et al;Preventing melasma recurrence:prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity; J Eur Acad Dermatol Venereol. 2012;26(5):611–618.